quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:05·269d
SECFiling
Elevation Oncology Inc. logo

SEC Form EFFECT filed by Elevation Oncology Inc.

ELEV· Elevation Oncology Inc.
Health Care
Original source

Companies

  • ELEV
    Elevation Oncology Inc.
    Health Care

Recent analyst ratings

  • Mar 24UpdateStephens$1.00
  • Mar 21UpdateLeerink Partners$1.00
  • Mar 21UpdateCitizens JMP-
  • Mar 21UpdatePiper Sandler$0.70
  • Jan 3UpdateWilliam Blair-
  • May 31UpdatePiper Sandler$10.00

Related

  • SEC262d
    SEC Form 15-12G filed by Elevation Oncology Inc.
  • SEC269d
    SEC Form EFFECT filed by Elevation Oncology Inc.
  • SEC269d
    Amendment: SEC Form SCHEDULE 13D/A filed by Elevation Oncology Inc.
  • INSIDER273d
    SEC Form 4 filed by Director Sandler Alan B.
  • INSIDER273d
    SEC Form 4 filed by Director Mootz Darcy
  • INSIDER273d
    SEC Form 4 filed by Director Elms Steve
  • INSIDER273d
    SEC Form 4 filed by Director Clackson Timothy P
  • INSIDER273d
    SEC Form 4 filed by Director Cherrington Julie M
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022